United Orthopedic Corporation United Orthopedic Corporation

United Orthopedic Corporation

4129

Rank in Stocks #16358
United Orthopedic Corporation is a firm dedicated to the research, development,... United Orthopedic Corporation is a firm dedicated to the research, development, manufacturing, and global distribution of advanced orthopedic implants and specialized surgical instruments. The company's extensive product offerings address a wide spectrum of orthopedic needs. Its comprehensive range of hip and knee solutions includes various artificial hip joints, partial hip replacements, specialized joints for large trochanteric fractures, and Moore hip prostheses. Uniquely, it also designs and supplies custom artificial hip and knee joints specifically tailored for individual tumor patients, alongside standard artificial knee replacement joints, revision systems, and restricted artificial knee joints. For spinal care, United Orthopedic manufactures vertebral fixation devices. Furthermore, its portfolio extends to injury and trauma products, which encompass a variety of orthopedic internal fixation items, bone plates, bone nails, bone pins, and bone screws. The company also functions as an OEM supplier for orthopedic internal fixation solutions and provides specialized lamb salvage systems. Beyond implants, United Orthopedic Corporation delivers orthopedic surgical equipment and the machinery necessary for its manufacturing. It also trades in special metal and plastic materials, actively engaging in the import and export of its products across international markets. With a global footprint, the company conducts business in Taiwan, across Asia, the Americas, Europe, Africa, and Australia. Established in 1993, United Orthopedic Corporation is headquartered in New Taipei City, Taiwan, and operates as a subsidiary of Chi-Yi Investment Co. Ltd.
Share Price
$2.22
Last synced: 2026-11-10
Market Cap
$214.32M
Change (1 day)
-0.14%
Change (1 year)
-44.97%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade United Orthopedic Corporation (4129)

Category

Healthcare
Operating Margin for United Orthopedic Corporation (4129)
Operating Margin as of November 2026 TTM: 11.55%
According to United Orthopedic Corporation's latest financial reports, its current operating margin (TTM) is 11.55%. At the end of 2025 the company had an operating margin of 13.10%.
Operating Margin history for United Orthopedic Corporation from 2016 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 11.55% -11.83%
2025 13.10% -2.31%
2024 13.41% -2.97%
2023 13.82% 27.96%
2022 10.80% 72.25%
2021 6.27% 63.71%
2020 3.83% 15.36%
2019 3.32% -9.29%
2018 3.66% -55.58%
2017 8.24% -26.95%
2016 11.28% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
15.24% -98.68%
US
18.08% -98.43%
IE
21.25% -98.16%
US
21.05% -98.18%
US
28.09% -97.57%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about United Orthopedic Corporation's operating margin

What is United Orthopedic Corporation's operating margin?

United Orthopedic Corporation's operating margin is 11.55%, as of Nov 2026.

What was United Orthopedic Corporation's operating margin in 2025?

In 2025, United Orthopedic Corporation's operating margin was 13.10%, compared with 13.41% in 2024.

How has United Orthopedic Corporation's operating margin changed since 2020?

From 2020 to 2025, United Orthopedic Corporation's operating margin was highest in 2023 (13.82%) and lowest in 2020 (3.83%).

How does United Orthopedic Corporation's operating margin compare with similar companies?

United Orthopedic Corporation's operating margin (11.55%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.